Home › Funds › UBS Group AG › TECX
UBS Group AG position in TECX
TECTONIC THERAPEUTIC INC · Health Care
Latest position (Q2 2026)15.05K sh
Reported value held$517.52K
Portfolio Weight0.00%
First reportedQ3 2024
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 3 | $91 | New |
| Q4 2024 | 10.77K | $497.44K | Add |
| Q1 2025 | 11.23K | $198.83K | Add |
| Q2 2025 | 34.24K | $680.31K | Add |
| Q3 2025 | 66.46K | $1.04M | Add |
| Q4 2025 | 31.21K | $651.14K | Reduce |
| Q1 2026 | 29.99K | $926.90K | Reduce |
| Q2 2026 | 15.05K | $517.52K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding TECX
- Fidelity Management & Research (FMR) 2.83M sh · $97.29M · Q2 2026
- BlackRock Inc 862.59K sh · $29.65M · Q2 2026
- Vanguard Group 599.90K sh · $12.51M · Q4 2025
- Geode Capital Management 270.46K sh · $9.30M · Q2 2026
- D. E. Shaw & Co 186.55K sh · $6.41M · Q2 2026
- Marshall Wace 172.10K sh · $5.92M · Q2 2026
- Millennium Management 165.53K sh · $5.69M · Q2 2026
- Wells Fargo & Co 117.43K sh · $4.04M · Q2 2026
- Northern Trust Corp 113.90K sh · $3.92M · Q2 2026
- Goldman Sachs Group 73.92K sh · $2.54M · Q2 2026
- Morgan Stanley 65.37K sh · $2.25M · Q2 2026
- JPMorgan Chase & Co 55.36K sh · $1.83M · Q2 2026